Membrane News and Research

RSS

Study is the first to show that there are mechanisms in place for the immune system to identify cancer cells

A study undertaken by biologists at the University of California, Berkeley, has found that damage to a cell's DNA sets off a chain reaction that leads to the increased expression of a marker recognized by the body's immune system.

6 Jul 2005

New drug to treat stroke complications tested in US for the first time as part of an international trial

A Roanoke, Va. woman is the first U. S. participant in an international, multi center trial of a new drug that shows promise in treating complications from a stroke.

1 Jul 2005

Viagra's non-blood pressure effect successfully mimics vasopressin action

Normally your kidneys filter about 50 gallons of blood a day, remove such waste as salts and minerals, and concentrate it into urine. When you exercise or don't take in water, your blood "thickens" and instead of removing water, the kidney reverses the process, pulls in water from the body that would normally go into the urine, and puts it into the blood, thus maintaining water balance.

29 Jun 2005

Treatment options for skull base tumors

It is estimated that in 2000, more than 359,000 persons were living with a diagnosis of a primary brain tumor in the United States. In 2005, it is estimated that nearly 12,800 deaths will be associated with malignant tumors of the brain and other parts of the central nervous system. Brain tumors are the leading cause of cancer-related deaths in children age 19 and younger.

28 Jun 2005

Scientists solve structure of a critical innate immune system protein

Scientists at The Scripps Research Institute have solved the structure of a crucial human immune system molecule called TLR3, an acronym for Toll-like receptor three. In an upcoming issue of the journal Science, the protein is described as a large horseshoe-shaped coil composed of 23 leucine-rich repeats (LRRs).

27 Jun 2005

If you know how viruses get into cells, you know how to better design drugs to keep them out

When it comes to gaining entry into cells, size matters. A team from Brown University and the Max Planck Institute for Metals Research has created a model that explains how viruses and other bioparticles slip inside cells without a special protein coating called clathrin.

27 Jun 2005

Finding may impact understanding of mechanical facets of many diseases

An international team led by Jeffrey J. Fredberg, professor of bioengineering and physiology at the Harvard School of Public Health, has found that the cell modulates its mechanical properties in much the same way as a glassblower shapes fine glassware.

20 Jun 2005

Claudin-1 regulates cellular transformation and metastatic behavior in colon cancer

Disruption of proteins expressed at the junctures between cells (known as tight junctions) is a hallmark of cancer cell invasion and spread (metastasis).

16 Jun 2005

First demonstration of a vaccine for Parkinson's

Researchers at the University of California, San Diego (UCSD) School of Medicine working with scientists at Elan Pharmaceuticals, have reported promising results in mice of a vaccine approach to treating Parkinson’s and similar diseases. These results appear in the June edition of the journal Neuron.

15 Jun 2005

SARS vaccine produced from plants

According to new research, a vaccine has been produced in genetically engineered tomato and tobacco plants, which triggers anti-SARS antibodies in mice.

15 Jun 2005

Nanotechnology used to smuggle a powerful chemotherapeutic drug inside tumor cells

University of Michigan scientists have created the nanotechnology equivalent of a Trojan horse to smuggle a powerful chemotherapeutic drug inside tumor cells - increasing the drug's cancer-killing activity and reducing its toxic side effects.

15 Jun 2005

Continuous drinking for as little as eight weeks affects learning and memory up to 12 weeks later

Rodent studies, for example, have shown that chronic alcohol consumption for six months or more can produce permanent deficits and neural damage. A rodent study in the June issue of Alcoholism: Clinical & Experimental Research is the first to show that continuous drinking for as little as eight weeks can produce deficits in learning and memory that last up to 12 weeks after drinking stopped.

14 Jun 2005

Scientists produce for the first time an infectious form of the hepatitis C virus in laboratory cultures of human cells

The finding, reported in the June 9 issue of Science Express, will allow scientists to study every stage of the HCV life cycle and develop drugs to treat this life-threatening disease that affects more than 170 million people around the world.

9 Jun 2005

Study of glial cells in the roundworm C. elegans may provide insight into a variety of human brain diseases

The key to understanding our brains may lie within a one-millimeter long worm, new research from Rockefeller University indicates. Reporting in the June issue of Developmental Cell, Shai Shaham, Ph.D., and graduate student Elliot Perens use the roundworm, C. elegans, to investigate the mysterious glial cell, which makes up 90 percent of the human brain and, when it malfunctions, can contribute to diseases like Parkinson's disease and schizophrenia.

9 Jun 2005

Several minute intermediate stage in virus-cell fusion may represent a window of opportunity for drug development

To ignite a life-threatening infection in the body, a virus such as HIV invades body cells by first merging, or fusing, with the cell's outer membrane. Once inside the cell, the invading microbe's genetic material takes over, turning the 'host' cell into a factory to produce more copies of the virus, which then spill out to invade other cells in the body.

8 Jun 2005

Simple blood test can quickly identify type of congestive heart failure

A simple blood test can quickly identify what type of congestive heart failure (CHF) a patient has, improving diagnostic accuracy; eliminating the need for extensive diagnostic tests, such as heart muscle biopsy or exploratory surgery; and enabling the patient to be treated sooner, according to a study published in the June 7 Journal of the American College of Cardiology.

6 Jun 2005

Membrane News and Research

Study is the first to show that there are mechanisms in place for the immune system to identify cancer cells

New drug to treat stroke complications tested in US for the first time as part of an international trial

Viagra's non-blood pressure effect successfully mimics vasopressin action

Treatment options for skull base tumors

Scientists solve structure of a critical innate immune system protein

If you know how viruses get into cells, you know how to better design drugs to keep them out

Finding may impact understanding of mechanical facets of many diseases

Claudin-1 regulates cellular transformation and metastatic behavior in colon cancer

First demonstration of a vaccine for Parkinson's

SARS vaccine produced from plants

Nanotechnology used to smuggle a powerful chemotherapeutic drug inside tumor cells

Continuous drinking for as little as eight weeks affects learning and memory up to 12 weeks later

Scientists produce for the first time an infectious form of the hepatitis C virus in laboratory cultures of human cells

Study of glial cells in the roundworm C. elegans may provide insight into a variety of human brain diseases

Several minute intermediate stage in virus-cell fusion may represent a window of opportunity for drug development

Simple blood test can quickly identify type of congestive heart failure

World first air purification technology for H5N1 Avian Influenza

Novel insights into how prion and other neurodegenerative diseases develop

The bacteria that cause food poisoning, bubonic plague, and whooping cough all deploy the same weapon to infect the body

Leprosy microbes lead scientists to immune discovery

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo